Supernus Pharmaceuticals, Inc. (SUPN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 3 ratings

View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
tambor 04/06/2013 3 months $5.45 $6.86 +25.87% 25 Active
Comments:
heathersandy 03/20/2013 1 Year $5.51 $6.86 +24.5% 24 Active
Comments: will be getting a good revenue stream from now on
cynthia m 03/18/2013 1 Year $5.06 $6.86 +35.57% 35 Active
Comments: 1 year outlook: $14
Chemistfrog 01/01/2013 3 months $7.17 $5.62 -21.62% -21 Ended
Comments: Oversold due to terrible offering but has 2 approved epilepsy drugs. Rest of pipeline looks strong.
JOKER66 11/30/2012 1 day $9.83 $8.02 -18.41% 18 Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.